verified that RAD51AP1, KIF2C, KIF20A,NUF2,PBK, and DEPDC1 are all potential biomarkers for the diagnosis and prognosis of ESCC and may be potential therapeutic targets for ESCC (41). Here, PBK is linked to esophageal squamous cell carcinoma.